Down 10.3%, Is Abbott Laboratories Stock a Buy on the Dip?
If you're trying to build a passive income stream to eventually fuel your dream retirement, Abbott Laboratories (NYSE: ABT) is a stock you probably want to know more about. This legendary dividend payer has raised its payouts by 264% over the last 10 years, and it has a little something for everyone.
In addition to its recent rapid dividend growth, cautious long-term investors love the stock because they know Abbott has raised its dividend payout for 50 consecutive years.
Growth-conscious investors appreciate Abbott's commitment to innovation, which has helped make it one of the world's leading providers of next-generation medical devices and diagnostics. However, sales of its COVID-19 diagnostic tests have fallen sharply, and they don't seem likely to recover.
Source Fool.com
Abbott Laboratories Stock
With 16 Buy predictions and not the single Sell prediction the community is currently very high on Abbott Laboratories.
As a result the target price of 116 € shows a slightly positive potential of 18.84% compared to the current price of 97.61 € for Abbott Laboratories.
